DexCom, Inc. (DXCM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:47AM EDT. Market open.
| Previous close | 137.87 |
| Open | 132.79 |
| Bid | 135.51 x 200 |
| Ask | 135.83 x 200 |
| Day's range | 134.45 - 139.24 |
| 52-week range | 74.75 - 142.00 |
| Volume | |
| Avg. volume | 3,081,608 |
| Market cap | 53.727B |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | 104.36 |
| EPS (TTM) | 1.30 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 151.32 |
ZacksWall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy?
Based on the average brokerage recommendation (ABR), DexCom (DXCM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ZacksDexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
ZacksAhead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.